JB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen its market share in the domestic branded formulation business. CEO Nikhil Chopra said the assets should be at the right valuation and have synergy with the existing business, with a payback period of seven to eight years.
J. B. Chemicals & Pharmaceuticals Limited is looking for acquisitions. JB Chemicals & Pharmaceuticals is evaluating assets for acquisitions to bolster market share in the domestic branded.
Get latest articles and stories on Latest News at LatestLY. JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 35 per cent increase in profit after tax at Rs 142 crore in the first quarter ended June 30, 2023. Latest News | JB Pharma Q1 PAT Grows 35 Pc to Rs 142 Cr.